Gujarat Themis Biosyn: Kindly refer to the Un-audited Standalone & Consolidated Financial Results for the quarter and half year…
Gujarat Themis Biosyn (GUJTHEM) filed a disclosure titled "Kindly refer to the Un-audited Standalone & Consolidated Financial Results for the quarter and half year ended 30.09.2026". The company is valued at about ₹5,044 crore.
What happened
Gujarat Themis Biosyn (GUJTHEM) filed a disclosure with the exchanges on 14 November 2026 at 04:13 PM titled "Kindly refer to the Un-audited Standalone & Consolidated Financial Results for the quarter and half year ended 30.09.2026".
Company snapshot
Gujarat Themis Biosyn is a small-cap company, with a market value of about ₹5,044 crore.
The stock last traded at ₹387.6, against a 52-week range of ₹225.1–₹470.1 (17.6% below the high).
Before this filing the shares had moved +3.9% over the month and +11.1% over three months. Average daily turnover over the last 20 sessions was about ₹7.5 crore.
Promoters held 59.33% at the end of Q2 FY27, down 11.53% points from the previous quarter. Foreign institutions owned 4.93% and domestic institutions 13.79%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 36 | 9.1 | 0.83 |
| Q2 FY26 | 78 | 23.3 | 1.31 |
| Q3 FY26 | 43 | 12.5 | 1.14 |
| Q4 FY26 | 44 | 10.9 | 0 |
| Q1 FY27 | 44 | 11.1 | 1.02 |
What history shows
BCEIE's records show 4 previous results filings from the company since May 2026.
After those filings, the stock gained 6.3% on average the next trading day and was down 1.1% on average after five days (2 filings with price data).
Market-wide, 11,788 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 7 Aug 2026 | Results- Unaudited Standalone And Consolidated Financial Results For… | +1.6% | −3.6% |
| 25 May 2026 | Board Meeting Outcome for Outcome Of Board Meeting Under Regulation… | +11.0% | +1.5% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 14 November 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.